Astera Labs Announces Financial Results for the First Quarter of Fiscal Year 2024

Astera Labs宣布2024财年第一季度的财务业绩

asteralabs · 06/30 23:30

SANTA CLARA, CA, U.S. – May 7, 2024 – Astera Labs (Nasdaq: ALAB), a global leader in semiconductor-based connectivity solutions for cloud and AI infrastructure, today announced preliminary financial results for the first quarter of fiscal 2024, ended March 31, 2024.

“Astera Labs started the year strong, achieving record revenue in the first quarter, driven by the accelerating deployment of AI infrastructure,” said Jitendra Mohan, Astera Labs’ Chief Executive Officer. “As hyperscalers embark on a significant transformation of their data centers to support AI applications with increased capital investment, we’re witnessing the emergence of a multi-year growth cycle. Our Intelligent Connectivity Platform, comprising of the COSMOS software suite and semiconductor-based PCIe, Ethernet, and CXL solutions, is uniquely positioned to support this growth and is foundational to deploying AI infrastructure at scale. In the first quarter, we further extended our connectivity platform and started sampling our third generation of Aries Retimers with support for PCIe 6.x and the industry’s first PCIe/CXL Smart Cable Modules for Active Electrical Cable applications to enable multi-rack GPU clustering.”

Q1 Financial Highlights

GAAP Financial Results:

Revenue of $65.3 million, up 29% sequentially and up 269% year-over-year
GAAP gross margin of 77.4%
GAAP operating loss of $83.0 million
GAAP net loss of $93.0 million
GAAP basic and diluted net loss per share attributable to common stockholders of ($1.77) on weighted-average shares outstanding of 52.5 million

Non-GAAP Financial Results (excluding the impact of stock compensation, employer payroll tax related to stock-based compensation from our IPO, income tax effects of non-GAAP adjustments, and certain other items):

Non-GAAP gross margin of 78.2%
Non-GAAP operating income of $15.9 million
Non-GAAP net income of $14.3 million
Pro forma non-GAAP diluted earnings per share of $0.10

Q1 and Recent Business Highlights

Expanded the widely deployed and field-tested Aries PCIe/CXL Smart DSP Retimer portfolio with the sampling of Aries 6 Retimers, the industry’s lowest power PCIe 6.x/CXL 3.x Retimer solution, to achieve higher bandwidth and extended reach across complex AI and compute topologies. Through collaboration with the industry’s leading GPU and CPU providers such as AMD, Arm, Intel, and NVIDIA, Aries 6 is being rigorously tested at Astera Labs’ Cloud-Scale Interop Lab and in customer platforms to minimize interoperation risk, lower system development costs, and reduce time to market. Aries 6 was demonstrated at NVIDIA GTC during the week of March 18th.
Announced sampling of Aries PCIe/CXL Smart Cable Modules for Active Electrical Cable applications to enable multi-rack GPU clustering and low-latency memory fabric connectivity within AI infrastructure. The solution drives an industry-leading seven meters of channel reach over flexible copper cables to seamlessly interconnect clusters of GPUs across rack enclosures.
Announced the pricing and closing of an initial public offering of 22,770,000 shares of Astera Labs common stock at a price to the public of $36.00 per share. Net proceeds to Astera Labs from the offering were $672.2 million after deducting underwriting discounts and commissions. The shares began trading on the NASDAQ Global Select Market under the ticker symbol “ALAB” on March 20, 2024.

Second Quarter Fiscal 2024 Financial Outlook

Based on current business trends and conditions, Q2 revenue is expected to increase within a range of 10% to 12% compared with the prior quarter. We also estimate the following:

GAAP Financial Outlook:

GAAP gross margin of approximately 77%
GAAP operating expenses of approximately $79 million
GAAP interest income of approximately $9 million
GAAP tax rate of approximately (20%)
GAAP diluted loss per share of approximately ($0.11) on weighted-average diluted shares outstanding of approximately 155 million

Non-GAAP Financial Outlook (excluding the impact of approximately $39 million of stock-based compensation and including $3 million of additional income taxes):

Non-GAAP gross margin of approximately 77%
Non-GAAP operating expenses of approximately $40 million
Non-GAAP tax rate of approximately 23%
Non-GAAP diluted earnings per share of approximately $0.11 on weighted-average diluted shares outstanding of approximately 180 million
ASTERA LABS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(In thousands)

	March 31, 2024	December 31, 2023
Assets
Current assets
Cash and cash equivalents	$ 696,077	$ 45,098
Marketable securities	105,314	104,215
Accounts receivable, net	16,757	8,335
Inventory	29,567	24,095
Prepaid expenses and other current assets	6,725	4,064
Total current assets	854,440	185,807
Property and equipment, net	7,581	4,712
Other assets	2,880	5,773
Total assets	$ 864,901	$ 196,292

Liabilities, Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit)
Current liabilities
Accounts payable	$ 11,465	$ 6,337
Accrued expenses and other current liabilities	34,122	28,742
Total current liabilities	45,587	35,079
Other liabilities	10,530	3,787
Total liabilities	56,117	38,866
Commitments and contingencies
Redeemable convertible preferred stock	—	255,127
Stockholders’ equity (deficit)
Common stock	16	4
Additional paid-in capital	1,027,197	27,411
Accumulated other comprehensive (loss) income	(59)	259
Accumulated deficit	(218,370)	(125,375)
Total stockholders’ equity (deficit)	808,784	(97,701)
Total liabilities, redeemable convertible preferred stock and stockholders’ equity (deficit)	$ 864,901	$ 196,292

ASTERA LABS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(In thousands, except per share amounts)

	Three Months Ended
	March 31, 2024	December 31, 2023	March 31, 2023
Revenue	$ 65,258	$ 50,514	$ 17,664
Cost of revenue	14,738	11,489	13,406
Gross profit	50,520	39,025	4,258

Operating expenses
Research and development	53,558	19,654	15,267
Sales and marketing	55,510	4,995	4,393
General and administrative	24,419	5,356	3,525
Total operating expenses	133,487	30,005	23,185
Operating (loss) income	(82,967)	9,020	(18,927)
Interest income	2,554	1,674	1,596
(Loss) Income before income taxes	(80,413)	10,694	(17,331)
Income tax provision (benefit)	12,582	(3,631)	123
Net (loss) income	$ (92,995)	$ 14,325	$ (17,454)

Net (loss) income per share attributable to common stockholders:
Basic and diluted	$ (1.77)	$ —	$ (0.49)
Weighted-average shares used in calculating net (loss) income per share attributable to common stockholders:
Basic	52,532	38,627	35,826
Diluted	52,532	47,636	35,826

ASTERA LABS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(In thousands)

	Three Months Ended
	March 31, 2024	March 31, 2023
Cash flows from operating activities
Net loss	$ (92,995)	$ (17,454)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities
Stock-based compensation	97,768	1,997
Inventory write-down	428	9,733
Depreciation	614	357
Non-cash operating lease expense	522	217
Warrants contra revenue	110	55
Accretion of discounts on marketable securities	(566)	(411)
Changes in operating assets and liabilities:
Accounts receivable, net	(8,422)	7,048
Inventory	(5,900)	458
Prepaid expenses and other assets	(2,666)	(411)
Accounts payable	4,973	(5,740)
Accrued expenses and other liabilities	10,224	563
Operating lease liability	(438)	(231)
Net cash provided by (used in) operating activities	3,652	(3,819)

Cash flows from investing activities
Purchases of property and equipment	(3,424)	(439)
Purchases of marketable securities	(23,308)	(22,346)
Maturities of marketable securities	9,365	13,000
Sales of marketable securities	13,116	45,082
Net cash (used in) provided by investing activities	(4,251)	35,297

Cash flows from financing activities
Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions	672,198	—
Payment of deferred offering costs	(1,756)	—
Proceeds from exercises of stock options, net of repurchases	1,247	31
Tax withholding related to net share settlements of restricted stock units	(20,111)	—
Net cash provided by financing activities	651,578	31
Net increase in cash and cash equivalents	650,979	31,509
Cash and cash equivalents
Beginning of the period	45,098	76,088
End of the period	$ 696,077	$ 107,597

ASTERA LABS, INC.

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (Unaudited)

(In thousands, except percentages and per share amounts)

	Three Months Ended
	March 31, 2024	December 31, 2023	March 31, 2023
GAAP gross profit	$ 50,520	$ 39,025	$ 4,258
Stock-based compensation expense upon IPO (1)	516	—	—
Stock-based compensation expense	12	8	5
Non-GAAP gross profit	$ 51,048	$ 39,033	$ 4,263

GAAP gross margin	77.4 %	77.3 %	24.1 %
Stock-based compensation expense upon IPO (1)	0.8 %	—	—
Non-GAAP gross margin	78.2 %	77.3 %	24.1 %

GAAP operating (loss) income	$ (82,967)	$ 9,020	$ (18,927)
Stock-based compensation expense upon IPO (1)	88,873	—	—
Stock-based compensation expense	8,895	3,299	1,997
Employer payroll tax related to stock-based compensation from IPO (2)	1,072	—	—
Non-GAAP operating income (loss)	$ 15,873	$ 12,319	$ (16,930)

GAAP net (loss) income	$ (92,995)	$ 14,325	$ (17,454)
Stock-based compensation expense upon IPO (1)	88,873	—	—
Stock-based compensation expense	8,895	3,299	1,997
Employer payroll tax related to stock-based compensation from IPO (2)	1,072	—	—
Income tax effect (3)	8,485	—	—
Non-GAAP net income (loss)	$ 14,330	$ 17,624	$ (15,457)

Net (loss) income per share attributable to common stockholders:
GAAP – basic and diluted (4)	$ (1.77)	$ —	$ (0.49)
Pro forma Non-GAAP – diluted	$ 0.10	$ 0.12	$ (0.12)

Weighted-average shares used to compute net (loss) income per share attributable to common stockholders:
GAAP – basic	52,532	38,627	35,826
GAAP – diluted	52,532	47,636	35,826
Pro forma Non-GAAP – diluted (5)	147,514	138,527	126,717

____________________

(1) Stock-based compensation expense recognized in connection with the vesting and settlement of RSUs that had previously met the time vesting condition and for which the liquidity event vesting condition was satisfied in connection with our IPO.

(2) Employer payroll taxes related to the vesting and settlement of RSUs, that had previously met the time vesting condition and for which the liquidity event vesting condition was satisfied in connection with our IPO.

(3) For the three months ended March 31, 2024, the non-GAAP tax rate of approximately 22% is calculated based on the tax laws in the jurisdictions in which we operate and exclude the impact of stock-based compensation expense and associated employer payroll taxes. The adjustments for the three months ended December 31, 2023 and March 31, 2023 were not material.

(4) GAAP basic and diluted net income per share attributable to common stockholders for the three months ended December 31, 2023 was zero as all net income was attributable to preferred stockholders.

(5) Reconciliation of GAAP weighted-average shares to pro forma Non-GAAP weighted-average shares. We present the pro-forma non-GAAP weighted-average shares to provide meaningful supplemental information of comparable shares for each periods presented. The pro forma weighted-average shares is calculated as follows:

	Three Months Ended
	March 31, 2024	December 31, 2023	March 31, 2023
Shares used to compute GAAP net (loss) income per share attributable to common stockholders – diluted	52,532	47,636	35,826
Weighted-average effect of the assumed conversion of redeemable convertible preferred stock from the beginning of the quarter	78,905	90,891	90,891
Effect of potentially dilutive equivalent shares	16,077	—	—
Shares used to compute pro forma non-GAAP net income (loss) per share- diluted	147,514	138,527	126,717

ASTERA LABS, INC.

SUPPLEMENTAL FINANCIAL INFORMATION

STOCK-BASED COMPENSATION EXPENSE (Unaudited)

(In thousands)

	Three Months Ended
	March 31, 2024	December 31, 2023	March 31, 2023
Cost of revenue	$ 528	$ 8	$ 5
Research and development	30,007	2,303	1,679
Sales and marketing	49,258	681	1
General and administrative	17,975	307	312
Total stock-based compensation expense (1)	$ 97,768	$ 3,299	$ 1,997

____________________

(1) Stock-based compensation expense recognized during the three months ended March 31, 2024 included $88.9 million cumulative stock-based compensation expense related to the vesting and settlement of restricted stock units that had previously met the time vesting condition and for which the liquidity event vesting condition was satisfied in connection with our IPO.

美国加州圣克拉拉 - 2024年5月7日 - Astera Labs（纳斯达克：ALAB）是云计算和人工智能基础设施的半导体连接解决方案的全球领导者，今天宣布了截至2024财年第一季度财务业绩的初步财务结果，该季度截至2024年3月31日。

Astera Labs首席执行官Jitendra Mohan表示：“Astera Labs在本财年第一季度取得了强劲的业绩，在AI基础设施加速部署的驱动下实现了创纪录的财务收入，随着超大规模企业开始在数据中心加大资本投入，以支持人工智能应用程序的重大转型，我们正在目睹多年的增长周期的出现。我们的智能连接平台包括COSMOS软件套件和基于半导体的PCIe，以太网和CXL解决方案，具有独特的市场地位，可支持此增长，并为大规模部署AI基础设施提供基础。第一季度，我们进一步扩展了我们的连接平台，并开始抽样我们第三代的Aries Retimers，支持PCIe 6.x和行业首款支持PCIe/CXL的智能电缆模块，以启用多机架GPU聚类。

Q1 Financial Highlights

Q1财务亮点

GAAP Financial Results:

根据通用会计准则的财务结果：

Revenue of $65.3 million, up 29% sequentially and up 269% year-over-year
GAAP gross margin of 77.4%
GAAP operating loss of $83.0 million
GAAP net loss of $93.0 million
GAAP basic and diluted net loss per share attributable to common stockholders of ($1.77) on weighted-average shares outstanding of 52.5 million

营业收入6530万美元，环比增长29%，同比增长269%
通用会计准则的毛利率为77.4%
通用会计准则的运营亏损为8300万美元
通用会计准则的净亏损为9300万美元
基础和稀释后每股普通股股东净亏损为1.77美元，基础加权平均股数为5250万股

非通用会计准则的财务结果（排除股票补偿、IPO相关的雇主薪资税、非通用会计调整的所得税影响以及某些其他项目）：

Non-GAAP gross margin of 78.2%
Non-GAAP operating income of $15.9 million
Non-GAAP net income of $14.3 million
Pro forma non-GAAP diluted earnings per share of $0.10

非通用会计准则的毛利率为78.2%
非通用会计准则的营业收入为1590万美元
非通用会计准则的净收入为1430万美元
Pro forma非通用会计准则稀释每股收益为0.10美元

Q1 and Recent Business Highlights

Q1和最近的业务亮点

Expanded the widely deployed and field-tested Aries PCIe/CXL Smart DSP Retimer portfolio with the sampling of Aries 6 Retimers, the industry’s lowest power PCIe 6.x/CXL 3.x Retimer solution, to achieve higher bandwidth and extended reach across complex AI and compute topologies. Through collaboration with the industry’s leading GPU and CPU providers such as AMD, Arm, Intel, and NVIDIA, Aries 6 is being rigorously tested at Astera Labs’ Cloud-Scale Interop Lab and in customer platforms to minimize interoperation risk, lower system development costs, and reduce time to market. Aries 6 was demonstrated at NVIDIA GTC during the week of March 18th.
Announced sampling of Aries PCIe/CXL Smart Cable Modules for Active Electrical Cable applications to enable multi-rack GPU clustering and low-latency memory fabric connectivity within AI infrastructure. The solution drives an industry-leading seven meters of channel reach over flexible copper cables to seamlessly interconnect clusters of GPUs across rack enclosures.
Announced the pricing and closing of an initial public offering of 22,770,000 shares of Astera Labs common stock at a price to the public of $36.00 per share. Net proceeds to Astera Labs from the offering were $672.2 million after deducting underwriting discounts and commissions. The shares began trading on the NASDAQ Global Select Market under the ticker symbol “ALAB” on March 20, 2024.

通过抽样Aries 6 Retimers，行业内功耗最低的PCIe 6.x/CXL 3.x Retimer解决方案，为复杂的AI和计算拓扑结构提供更高带宽和扩展范围，扩展了广泛部署和经过现场测试的Aries PCIe/CXL Smart DSP Retimer组合。通过与AMD、Arm、Intel和NVIDIA等行业领先的GPU和CPU供应商的合作，Aries 6正在Astera Labs的云级互操作性实验室和客户平台中进行严格测试，以最小化互操作风险、降低系统开发成本和缩短产品上市时间。Aries 6已在3月18日的NVIDIA GTC展会上进行了演示。
宣布Aries PCIe/CXL智能电缆模块的抽样，用于启用多机架GPU聚类和低延迟内存基础设施连接。该解决方案通过灵活的铜质电缆驱动7米的信道距离，无缝连接机架之间的GPU群。
宣布了Astera Labs普通股的首次公开发行于2024年3月20日开始在纳斯达克全球精选市场上交易，股票代码为“ALAB”，普通股发行数量为22,770,000股，发行价格为每股36.00美元。扣除承销折扣和佣金后，Astera Labs从发行中获得的净收益为6.722亿美元。

Second Quarter Fiscal 2024 Financial Outlook

2024财年第二季度财务前景

Based on current business trends and conditions, Q2 revenue is expected to increase within a range of 10% to 12% compared with the prior quarter. We also estimate the following:

根据当前的业务趋势和状况，预计Q2收入将较上季度增长10%至12%。我们还预计以下情况：

GAAP Financial Outlook:

GAAP财务展望：

GAAP gross margin of approximately 77%
GAAP operating expenses of approximately $79 million
GAAP interest income of approximately $9 million
GAAP tax rate of approximately (20%)
GAAP diluted loss per share of approximately ($0.11) on weighted-average diluted shares outstanding of approximately 155 million

GAAP毛利率约为77%
GAAP营业费用约为7900万美元
GAAP利息收入约为900万美元
GAAP税率约为（20%）
GAAP加权平均摊薄股份约为1.55亿股，每股摊薄亏损约为0.11美元

Non-GAAP Financial Outlook (excluding the impact of approximately $39 million of stock-based compensation and including $3 million of additional income taxes):

非GAAP财务展望（不包括约3900万美元的股权酬劳影响，包括300万美元的额外所得税）：

Non-GAAP gross margin of approximately 77%
Non-GAAP operating expenses of approximately $40 million
Non-GAAP tax rate of approximately 23%
Non-GAAP diluted earnings per share of approximately $0.11 on weighted-average diluted shares outstanding of approximately 180 million

ASTERA LABS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(In thousands)

非GAAP毛利率约为77%
非GAAP营业费用约为4000万美元
非GAAP税率约为23%
非GAAP加权平均摊薄股份约为1.8亿股，每股摊薄收益约为0.11美元

ASTERA LABS, INC.

基本报表资产负债表（未经审计）

（以千为单位）

	March 31, 2024	December 31, 2023
Assets
Current assets
Cash and cash equivalents	$ 696,077	$ 45,098
Marketable securities	105,314	104,215
Accounts receivable, net	16,757	8,335
Inventory	29,567	24,095
Prepaid expenses and other current assets	6,725	4,064
Total current assets	854,440	185,807
Property and equipment, net	7,581	4,712
Other assets	2,880	5,773
Total assets	$ 864,901	$ 196,292

Liabilities, Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit)
Current liabilities
Accounts payable	$ 11,465	$ 6,337
Accrued expenses and other current liabilities	34,122	28,742
Total current liabilities	45,587	35,079
Other liabilities	10,530	3,787
Total liabilities	56,117	38,866
Commitments and contingencies
Redeemable convertible preferred stock	—	255,127
Stockholders’ equity (deficit)
Common stock	16	4
Additional paid-in capital	1,027,197	27,411
Accumulated other comprehensive (loss) income	(59)	259
Accumulated deficit	(218,370)	(125,375)
Total stockholders’ equity (deficit)	808,784	(97,701)
Total liabilities, redeemable convertible preferred stock and stockholders’ equity (deficit)	$ 864,901	$ 196,292

	3月31日 2024	12月31日 2023
资产
流动资产
现金及现金等价物	$ 696,077	$ 45,098
有价证券	105,314	104,215
应收账款净额	16,757	8,335
库存	29,567	24,095
资产预付款和其他流动资产的变动	6,725	4,064
总流动资产	854,440	185,807
资产和设备，净值	7,581	4,712
其他	2,880	5,773
总资产	$ 864,901	$ 196,292

负债，可转换优先股和股东权益（赤字）
流动负债
应付账款	$11,465	$6,337
应计费用及其他流动负债	34,122	28,742
流动负债合计	45,587	35,079
其他负债	10,530	3,787
负债合计	56,117	38,866
承诺和 contingencies
可转换优先股	—	255,127
股东权益（赤字）
普通股	16	4
额外实收资本	1,027,197	27,411
已实现其他综合收益 (损失)	(59)	259
累积赤字	(218,370)	(125,375)
股东权益（赤字）	808,784	(97,701)
总负债、可赎回优先股和股东权益（赤字）	$ 864,901	$ 196,292

ASTERA LABS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

基本财务报表(未经审计)

(In thousands, except per share amounts)

2024年4月27日

	Three Months Ended
	March 31, 2024	December 31, 2023	March 31, 2023
Revenue	$ 65,258	$ 50,514	$ 17,664
Cost of revenue	14,738	11,489	13,406
Gross profit	50,520	39,025	4,258

Operating expenses
Research and development	53,558	19,654	15,267
Sales and marketing	55,510	4,995	4,393
General and administrative	24,419	5,356	3,525
Total operating expenses	133,487	30,005	23,185
Operating (loss) income	(82,967)	9,020	(18,927)
Interest income	2,554	1,674	1,596
(Loss) Income before income taxes	(80,413)	10,694	(17,331)
Income tax provision (benefit)	12,582	(3,631)	123
Net (loss) income	$ (92,995)	$ 14,325	$ (17,454)

Net (loss) income per share attributable to common stockholders:
Basic and diluted	$ (1.77)	$ —	$ (0.49)
Weighted-average shares used in calculating net (loss) income per share attributable to common stockholders:
Basic	52,532	38,627	35,826
Diluted	52,532	47,636	35,826

	三个月之内结束
	3月31日 2024	12月31日 2023	3月31日 2023
营业收入	$ 65,258	$ 50,514	$ 17,664
营业收入成本	14,738	11,489	13,406
毛利润	50,520	39,025	4,258

营业费用
研发	53,558	19,654	15,267
销售及营销费用	55,510	4,995	4,393
普通和管理	24,419	5,356	3,525
营业费用总计	133,487	30,005	23,185
营业（亏损）收入	(82,967)	9,020	(18,927)
利息收入	2,554	1,674	1,596
(损失)税前收入	(80,413)	10,694	(17,331)
所得税负担（利益）	12,582	(3,631)	123
净（亏损）利润	（92,995）美元	$ 14,325	（17,454）美元

每股净(亏损)收益归属于普通股股东：
基本和稀释	$ (1.77)	$ —	$ (0.49)
计算每股归属于普通股股东的净(亏损)收益所使用的加权平均股数:
基本	52,532	38,627	35,826
摊薄	52,532	47636	35,826

ASTERA LABS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

简化的现金流量表（未经审计）

(In thousands)

（以千为单位）

	Three Months Ended
	March 31, 2024	March 31, 2023
Cash flows from operating activities
Net loss	$ (92,995)	$ (17,454)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities
Stock-based compensation	97,768	1,997
Inventory write-down	428	9,733
Depreciation	614	357
Non-cash operating lease expense	522	217
Warrants contra revenue	110	55
Accretion of discounts on marketable securities	(566)	(411)
Changes in operating assets and liabilities:
Accounts receivable, net	(8,422)	7,048
Inventory	(5,900)	458
Prepaid expenses and other assets	(2,666)	(411)
Accounts payable	4,973	(5,740)
Accrued expenses and other liabilities	10,224	563
Operating lease liability	(438)	(231)
Net cash provided by (used in) operating activities	3,652	(3,819)

Cash flows from investing activities
Purchases of property and equipment	(3,424)	(439)
Purchases of marketable securities	(23,308)	(22,346)
Maturities of marketable securities	9,365	13,000
Sales of marketable securities	13,116	45,082
Net cash (used in) provided by investing activities	(4,251)	35,297

Cash flows from financing activities
Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions	672,198	—
Payment of deferred offering costs	(1,756)	—
Proceeds from exercises of stock options, net of repurchases	1,247	31
Tax withholding related to net share settlements of restricted stock units	(20,111)	—
Net cash provided by financing activities	651,578	31
Net increase in cash and cash equivalents	650,979	31,509
Cash and cash equivalents
Beginning of the period	45,098	76,088
End of the period	$ 696,077	$ 107,597

	三个月之内结束
	3月31日 2024	3月31日 2023
经营活动现金流
净亏损	（92,995）美元	（17,454）美元
调整以将净亏损调节为经营活动中提供的现金净额
以股票为基础的报酬计划	97,768	1,997
存货减值	428	9,733
折旧费用	614	357
非现金租赁费用	522	217
Warrants contra revenue	110	55
Accretion of discounts on marketable securities	（566）	(411)
经营性资产和负债变动:
应收账款净额	（8,422）	7,048
库存	(5,900)	458
预付款项和其他资产	(2,666)	(411)
应付账款	4,973	(5,740)
应计费用及其他负债	10,224	563
经营租赁负债	(438)	(231)
经营活动产生的净现金流量	3,652	(3,819)

投资活动现金流量
购买固定资产	(3,424)	(439)
购买有市场流通的证券	(23,308)	(22,346)
有价证券到期收益	9,365	13,000
可变市场证券销售	13,116	45,082
投资活动的净现金流量(使用)/提供的净现金流量	(4,251)	35,297

筹资活动现金流量
发行普通股与初始公开发行相关的净额，扣除承销折扣和佣金	672,198	—
支付推迟发行成本	(1,756)	—
行使股票期权后回购的净额	1,247	31
与受限制股票单位净份额结算相关的税款代扣	(20,111)	—
筹资活动产生的现金净额	651,578	31
现金及现金等价物净增加额	650,979	31,509
现金及现金等价物
期初	45,098	76,088
期末	$ 696,077	$ 107,597

ASTERA LABS, INC.

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (Unaudited)

GAAP和非GAAP财务衡量的调解（未经审计）

(In thousands, except percentages and per share amounts)

（以千为单位，除百分比和每股金额外）

	Three Months Ended
	March 31, 2024	December 31, 2023	March 31, 2023
GAAP gross profit	$ 50,520	$ 39,025	$ 4,258
Stock-based compensation expense upon IPO (1)	516	—	—
Stock-based compensation expense	12	8	5
Non-GAAP gross profit	$ 51,048	$ 39,033	$ 4,263

GAAP gross margin	77.4 %	77.3 %	24.1 %
Stock-based compensation expense upon IPO (1)	0.8 %	—	—
Non-GAAP gross margin	78.2 %	77.3 %	24.1 %

GAAP operating (loss) income	$ (82,967)	$ 9,020	$ (18,927)
Stock-based compensation expense upon IPO (1)	88,873	—	—
Stock-based compensation expense	8,895	3,299	1,997
Employer payroll tax related to stock-based compensation from IPO (2)	1,072	—	—
Non-GAAP operating income (loss)	$ 15,873	$ 12,319	$ (16,930)

GAAP net (loss) income	$ (92,995)	$ 14,325	$ (17,454)
Stock-based compensation expense upon IPO (1)	88,873	—	—
Stock-based compensation expense	8,895	3,299	1,997
Employer payroll tax related to stock-based compensation from IPO (2)	1,072	—	—
Income tax effect (3)	8,485	—	—
Non-GAAP net income (loss)	$ 14,330	$ 17,624	$ (15,457)

Net (loss) income per share attributable to common stockholders:
GAAP – basic and diluted (4)	$ (1.77)	$ —	$ (0.49)
Pro forma Non-GAAP – diluted	$ 0.10	$ 0.12	$ (0.12)

Weighted-average shares used to compute net (loss) income per share attributable to common stockholders:
GAAP – basic	52,532	38,627	35,826
GAAP – diluted	52,532	47,636	35,826
Pro forma Non-GAAP – diluted (5)	147,514	138,527	126,717

	三个月之内结束
	3月31日 2024	12月31日 2023	3月31日 2023
GAAP毛利润	$ 50,520	$ 39,025	$ 4,258
IPO股票授予激励支出(1)	516	—	—
股票补偿费用	12	8	5
非通用会计原则毛利润	$ 51,048	$ 39,033	$ 4,263

GAAP毛利率	77.4 %	77.3 %	24.1 %
IPO股票授予激励支出(1)	0.8%	—	—
非GAAP毛利率	78.2 %	77.3 %	24.1 %

GAAP营业（亏损）收入	$ (82,967)	$ 9,020	$ (18,927)
IPO股票授予激励支出(1)	88,873	—	—
股票补偿费用	8,895	3,299	1,997
与IPO相关的雇主薪酬税(2)	1,072	—	—
非通用会计原则下的营业收入（亏损）	$ 15,873	$ 12,319	$ (16,930)

按照通用会计准则，净（亏损）收益	$ (92,995)	$ 14,325	$ (17,454)
IPO股票授予激励支出(1)	88,873	—	—
股票补偿费用	8,895	3,299	1,997
与IPO相关的雇主薪酬税(2)	1,072	—	—
所得税影响（3）	8,485	—	—
非GAAP净收入（净亏损）	$ 14,330	$ 17,624	$ (15,457)

每股净(亏损)收益归属于普通股股东：
GAAP - 基本和稀释(4)	$ (1.77)	$ —	$ (0.49)
非GAAP勾选 - 稀释	$ 0.10	$ 0.12	$ (0.12)

计算净(亏损)收益每股归属于普通股股东的加权平均股数：
GAAP - 基本	52,532	38,627	35826
GAAP - 稀释	52,532	47,636	35826
Pro forma Non-GAAP – diluted (5)	147514	138527	126717

____________________

（1）在IPO时，满足时间限制以及流动性事件限制的RSU的归属股日期，以及与之相关的股票补偿费用。

（2）与IPO相关的RSU的授予和行权，雇主的工资税。

（3）截至2024年3月31日的三个月，非GAAP税率约为22％，根据我们运营地区的税法计算，并排除股票补偿费用和相关的雇主工资税影响。 2023年12月31日和2023年3月31日的调整不重要。

(4) GAAP basic and diluted net income per share attributable to common stockholders for the three months ended December 31, 2023 was zero as all net income was attributable to preferred stockholders.

截至2023年12月31日的三个月，按照GAAP基本和摊薄的每股净收益归属于普通股股东为零，因为所有净收益均归属于优先股股东。

调和GAAP加权平均股份至调整后的非GAAP加权平均股份。我们提供调整后的非GAAP加权平均股份，以提供独立于股份类别的可比份额的有意义的补充信息。以下是调整后的加权平均股份的计算方法：

	Three Months Ended
	March 31, 2024	December 31, 2023	March 31, 2023
Shares used to compute GAAP net (loss) income per share attributable to common stockholders – diluted	52,532	47,636	35,826
Weighted-average effect of the assumed conversion of redeemable convertible preferred stock from the beginning of the quarter	78,905	90,891	90,891
Effect of potentially dilutive equivalent shares	16,077	—	—
Shares used to compute pro forma non-GAAP net income (loss) per share- diluted	147,514	138,527	126,717

	三个月之内结束
	3月31日 2024	12月31日 2023	3月31日 2023
用于计算基本和摊薄的每股GAAP净（损）收益归属于普通股股东的股份 - 摊薄	52532	47636	35826
从本季度开始的可赎回可转换优先股的假定转换影响的加权影响股份	78905	90891	90891
潜在稀释等效股影响	16077	—	—
用于计算摊薄后的非通用会计净利润（亏损）的股份	147,514	138,527	126,717

ASTERA LABS, INC.

SUPPLEMENTAL FINANCIAL INFORMATION

补充财务信息

STOCK-BASED COMPENSATION EXPENSE (Unaudited)

股份补偿费用（未经审计）

(In thousands)

（以千为单位）

	Three Months Ended
	March 31, 2024	December 31, 2023	March 31, 2023
Cost of revenue	$ 528	$ 8	$ 5
Research and development	30,007	2,303	1,679
Sales and marketing	49,258	681	1
General and administrative	17,975	307	312
Total stock-based compensation expense (1)	$ 97,768	$ 3,299	$ 1,997

	三个月之内结束
	3月31日 2024	12月31日 2023	3月31日 2023
营业收入成本	$ 528	$ 8	$ 5
研发	30,007	2,303	1,679
销售及营销费用	49,258	681	1
普通和管理	17,975	307	312
总股份为基础的补偿费用(1)	$97,768	$3,299	$1,997

____________________

(1) 控件周期内股份补偿费用共计88.9百万美元，与公司首次公开发行(IPO)相关的限制性股票单元(已达到时间限制条件并满足流动性事件限制条件)解除限制和结算。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

Astera Labs Announces Financial Results for the First Quarter of Fiscal Year 2024

Astera Labs Announces Financial Results for the First Quarter of Fiscal Year 2024

风险及免责提示

声明